{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:49:19Z","timestamp":1759798159486,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"DOI":"10.7759\/cureus.93937","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T16:24:56Z","timestamp":1759767896000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence and Predictors of Pulmonary Embolism Recurrence and Mortality in Patients With Lung Cancers"],"prefix":"10.7759","author":[{"given":"Reem F","family":"Almesfir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada F","family":"Alqubaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alkhelaifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Galil","family":"Abdel Gader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad A","family":"Aleidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164 Suppl 1","author":"Lyman GH","year":"2018","unstructured":"Lyman GH, Culakova E, Poniewierski MS, Kuderer NM. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018, 164 Suppl 1:S112-8. 10.1016\/j.thromres.2018.01.028","journal-title":"Thromb Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2390200","article-title":"Incidence and risk factors of VTE in lung cancer: a meta-analysis","volume":"56","author":"Yang R","year":"2024","unstructured":"Yang R, Wang H, Liu D, Li W. Incidence and risk factors of VTE in lung cancer: a meta-analysis. Ann Med. 2024, 56:2390200. 10.1080\/07853890.2024.2390200","journal-title":"Ann Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26008","article-title":"Lung cancer and pulmonary embolism: what is the relationship? A review","volume":"9","author":"Li Y","year":"2018","unstructured":"Li Y, Shang Y, Wang W, Ning S, Chen H. Lung cancer and pulmonary embolism: what is the relationship? A review. J Cancer. 2018, 9:3046-57. 10.7150\/jca.26008","journal-title":"J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2009.866","article-title":"Virchow's contribution to the understanding of thrombosis and cellular biology","volume":"8","author":"Kumar DR","year":"2010","unstructured":"Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH. Virchow's contribution to the understanding of thrombosis and cellular biology. Clin Med Res. 2010, 8:168-72. 10.3121\/cmr.2009.866","journal-title":"Clin Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume S","year":"2022","unstructured":"Koizume S, Miyagi Y. Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications. Br J Cancer. 2022, 127:2099-107. 10.1038\/s41416-022-01968-3","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00504-6","article-title":"Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer","volume":"11","author":"Ahmadi SE","year":"2023","unstructured":"Ahmadi SE, Shabannezhad A, Kahrizi A, et al.. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. Biomark Res. 2023, 11:60. 10.1186\/s40364-023-00504-6","journal-title":"Biomark Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2007.12.005","article-title":"Thrombin generation, fibrin clot formation and hemostasis","volume":"38","author":"Wolberg AS","year":"2008","unstructured":"Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci. 2008, 38:15-23. 10.1016\/j.transci.2007.12.005","journal-title":"Transfus Apher Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010100","article-title":"Thrombin generation and cancer: contributors and consequences","author":"Reddel CJ","year":"2019","unstructured":"Reddel CJ, Tan CW, Chen VM. Thrombin generation and cancer: contributors and consequences. 2019. 10.3390\/cancers11010100"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.3113","article-title":"JAMA oncology patient page. Performance status in patients with cancer","volume":"1","author":"West HJ","year":"2015","unstructured":"West HJ, Jin JO. JAMA oncology patient page. Performance status in patients with cancer. JAMA Oncol. 2015, 1:998. 10.1001\/jamaoncol.2015.3113","journal-title":"JAMA Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al.. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-655. 10.1097\/00000421-198212000-00014","journal-title":"Am J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.07.008","article-title":"Performance status and long-term outcomes in cancer-associated pulmonary embolism: insights from the hokusai-VTE cancer study","volume":"4","author":"Farmakis IT","year":"2022","unstructured":"Farmakis IT, Barco S, Mavromanoli AC, Konstantinides SV, Valerio L. Performance status and long-term outcomes in cancer-associated pulmonary embolism: insights from the hokusai-VTE cancer study. JACC CardioOncol. 2022, 4:507-18. 10.1016\/j.jaccao.2022.07.008","journal-title":"JACC CardioOncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2020.04.006","article-title":"The role of performance status in small-cell lung cancer in the era of immune checkpoint inhibitors","volume":"21","author":"Friedlaender A","year":"2020","unstructured":"Friedlaender A, Liu SV, Passaro A, Metro G, Banna G, Addeo A. The role of performance status in small-cell lung cancer in the era of immune checkpoint inhibitors. Clin Lung Cancer. 2020, 21:e539-43. 10.1016\/j.cllc.2020.04.006","journal-title":"Clin Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37120","article-title":"Association of performance status with survival in patients with advanced non-small cell lung cancer treated with pembrolizumab monotherapy","volume":"4","author":"Sehgal K","year":"2021","unstructured":"Sehgal K, Gill RR, Widick P, et al.. Association of performance status with survival in patients with advanced non-small cell lung cancer treated with pembrolizumab monotherapy. JAMA Netw Open. 2021, 4:e2037120. 10.1001\/jamanetworkopen.2020.37120","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179394","article-title":"Links between Infections, lung cancer, and the immune system","volume":"22","author":"Budisan L","year":"2021","unstructured":"Budisan L, Zanoaga O, Braicu C, et al.. Links between Infections, lung cancer, and the immune system. Int J Mol Sci. 2021, 22:10.3390\/ijms22179394","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/104990911988683","article-title":"Systemic inflammation and nutritional status in patients on palliative cancer care: a systematic review of observational studies","volume":"37","author":"Cordeiro LAF","year":"2020","unstructured":"Cordeiro LAF, Silva TH, de Oliveira LC, Neto JFN. Systemic inflammation and nutritional status in patients on palliative cancer care: a systematic review of observational studies. Am J Hosp Palliat Care. 2020, 37:565-571. 10.1177\/104990911988683","journal-title":"Am J Hosp Palliat Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7150\/jca.73130","article-title":"Nutritional support in cancer patients: update of the italian intersociety working group practical recommendations","volume":"13","author":"Caccialanza R","year":"2022","unstructured":"Caccialanza R, Cotogni P, Cereda E, et al.. Nutritional support in cancer patients: update of the italian intersociety working group practical recommendations. J Cancer. 2022, 13:2705-16. 10.7150\/jca.73130","journal-title":"J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1361800","article-title":"Nutritional care for cancer patients: are we doing enough?","volume":"11","author":"Da Prat V","year":"2024","unstructured":"Da Prat V, Pedrazzoli P, Caccialanza R. Nutritional care for cancer patients: are we doing enough?. Front Nutr. 2024, 11:1361800. 10.3389\/fnut.2024.1361800","journal-title":"Front Nutr"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan F","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021, 398:64-77.","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14774","article-title":"Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: a prospective study","volume":"18","author":"Posch F","year":"2020","unstructured":"Posch F, Riedl J, Reitter EM, et al.. Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: a prospective study. J Thromb Haemost. 2020, 18:1348-56. 10.1111\/jth.14774","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_107_22","article-title":"High D-dimer level at first incident cancer-associated venous thromboembolism is a predictor for recurrence: a retrospective cohort study","volume":"14","author":"Al-Eidan FAS","year":"2023","unstructured":"Al-Eidan FAS, Alotaibi SA, Almajid HM, Alnahedh TA, Abdel Gadir AG. High D-dimer level at first incident cancer-associated venous thromboembolism is a predictor for recurrence: a retrospective cohort study. J Appl Hematol. 2023, 14:35-40. 10.4103\/joah.joah_107_22","journal-title":"J Appl Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_52_23","article-title":"Incidence and predictors of venous thromboembolism and mortality in Saudi lung cancer patients: a retrospective two-center cohort study","volume":"15","author":"Aleidan FAS","year":"2024","unstructured":"Aleidan FAS, Almesfir R, Alqudaibi N, Alqhatani S, Abuelgasim KA. Incidence and predictors of venous thromboembolism and mortality in Saudi lung cancer patients: a retrospective two-center cohort study. J Appl Hematol. 2024, 15:35-41. 10.4103\/joah.joah_52_23","journal-title":"J Appl Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051582","article-title":"Predicting the risk of recurrent venous thromboembolism: current challenges and future opportunities","volume":"9","author":"Stevens H","year":"2020","unstructured":"Stevens H, Peter K, Tran H, McFadyen J. Predicting the risk of recurrent venous thromboembolism: current challenges and future opportunities. J Clin Med. 2020, 9:10.3390\/jcm9051582","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1317","article-title":"Serum albumin is inversely associated with portal vein thrombosis in cirrhosis","volume":"3","author":"Basili S","year":"2019","unstructured":"Basili S, Carnevale R, Nocella C, et al.. Serum albumin is inversely associated with portal vein thrombosis in cirrhosis. Hepatol Commun. 2019, 3:504-12. 10.1002\/hep4.1317","journal-title":"Hepatol Commun"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.06.018","article-title":"Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients","volume":"22","author":"Valeriani E","year":"2024","unstructured":"Valeriani E, Pannunzio A, Palumbo IM, et al.. Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients. J Thromb Haemost. 2024, 22:2823-33. 10.1016\/j.jtha.2024.06.018","journal-title":"J Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-021-01618-4","article-title":"The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis","volume":"16","author":"Ma M","year":"2021","unstructured":"Ma M, Cao R, Wang W, et al.. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis. J Cardiothorac Surg. 2021, 16:243. 10.1186\/s13019-021-01618-4","journal-title":"J Cardiothorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395255-incidence-and-predictors-of-pulmonary-embolism-recurrence-and-mortality-in-patients-with-lung-cancers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T16:24:57Z","timestamp":1759767897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395255-incidence-and-predictors-of-pulmonary-embolism-recurrence-and-mortality-in-patients-with-lung-cancers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.93937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}